Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Shorts -- Ignore unavailable to you. Want to Upgrade?

To: (no name provided) who wrote (43)	12/14/1997 12:57:00 AM
From: poodle	Read Replies (1) \| Respond to of 61

Thanks for answer. I still can't get it: if it is so clear, why several professionals did not see it? 40-60 mg were effective 40-50% in comparison with 20% from placebo. May I ask you to post toxic doses and corresponding effects? Thank you. Buyback is a normal answer of the company with hammered stock. I would not make any long term "short" or "long" conclusions, but on Mon stock should jump (there were also some products announcements, did not have time to check yet). Regards.